Skip to content

Clinical trials

Migraine Disorders trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Migraine Disorders Country / region: Norway Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20071
20091
20121
20132
20152
20172
20181
20192
20211
20222
20232
20244
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting4
Terminated3
Not yet recruiting1
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Norwegian University of Science and Technology6
St. Olavs Hospital4
Nordlandssykehuset HF3
Oslo University Hospital2
AbbVie1
Allergan1
Amgen1
Boston Scientific Corporation1
ElectroCore INC1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Migraine Disorders28
Headache7
Headache Disorders2
COVID-191
Chronic Disease1
Cluster Headache1
Diabetes Insipidus1
Epilepsy1
Headache Disorders, Secondary1
Migraine with Aura1

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.